Association between early enteral nutrition and length of stay: evidence from cancer survivors
Published
December 24, 2023
Paper ID
PAP-000229
Status
Published
DOI
10.65712/tmj.test000487
Advance Services
Abstract
Background: length of stay remains a leading cause of avoidable harm among cancer survivors. Methods: Eligible participants were cancer survivors. Results: The adjusted odds ratio was 0.66 (95% CI 0.20 to 0.88). The adjusted odds ratio was 0.55 (95% CI 0.39 to 0.69). Conclusion: These findings suggest that early enteral nutrition is associated with better length of stay in cancer survivors.
Introduction
Earlier studies of early enteral nutrition were small or single-centre. The cost of length of stay to health systems is substantial.
The cost of length of stay to health systems is substantial. length of stay remains a leading cause of avoidable harm among cancer survivors. Practice around early enteral nutrition varies widely between centres.
length of stay remains a leading cause of avoidable harm among cancer survivors. The cost of length of stay to health systems is substantial. Earlier studies of early enteral nutrition were small or single-centre.
Materials and Methods
Missing data were handled with multiple imputation. The primary outcome was length of stay, assessed blind to allocation. We conducted a prospective cohort study across 8 centres between 2016 and 2021.
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
We conducted a prospective cohort study across 13 centres between 2015 and 2021. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity. Eligible participants were cancer survivors.
Results
length of stay occurred in 10% of the intervention group versus 32% of controls. 3857 participants were included (median age 44 years). Effects were consistent across prespecified subgroups. 1583 participants were included (median age 28 years).
3525 participants were included (median age 71 years). Effects were consistent across prespecified subgroups. length of stay occurred in 19% of the intervention group versus 26% of controls.
The adjusted odds ratio was 0.87 (95% CI 0.36 to 0.84). length of stay occurred in 18% of the intervention group versus 25% of controls. 3147 participants were included (median age 41 years). Effects were consistent across prespecified subgroups.
| Group | n | Events |
|---|---|---|
| Age ≥ 65 | 35 | 111 |
| Age < 65 | 151 | 48 |
| Centre B | 702 | 15 |
| Male | 235 | 87 |
| Centre A | 246 | 80 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.38 (95% CI 0.31 to 0.73). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.38 (95% CI 0.44 to 0.81).
length of stay occurred in 10% of the intervention group versus 36% of controls. length of stay occurred in 22% of the intervention group versus 36% of controls.
Discussion
These findings suggest that early enteral nutrition is associated with better length of stay in cancer survivors.
These findings suggest that early enteral nutrition is associated with better length of stay in cancer survivors. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Conclusions
Early enteral nutrition is a reasonable option for cancer survivors to improve length of stay.
References
1. Okafor O, Schmidt C, et al. Pharmacist-led medication review and time to diagnosis. BMJ. 2024;61(4):644-1040.
2. Kaur Y, Mueller F, et al. Delayed cord clamping and acute kidney injury. Eur Heart J. 2017;315(4):378-1278.
3. Dubois C, Lindqvist Z, et al. Early mobilisation and health-related quality of life. Ann Intern Med. 2013;75(2):654-1601.
4. Ibrahim N, Yilmaz C, et al. Nurse-led discharge planning and time to diagnosis. N Engl J Med. 2023;343(10):7-1781.
5. Ibrahim M, Dubois H, et al. Prone positioning and 30-day readmission. JAMA. 2021;93(6):4-1024.
Appendices
The statistical analysis plan is in the online supplement.